ADVERTISEMENT

ABB India Q4 Results: Profit Up 56%, Revenue Rises 22%

The Ebitda margin expanded to 19.5% versus 15.1% in the year-ago period.

<div class="paragraphs"><p>ABB India Ltd.'s net profit rose 56% in the quarter ended December, according to the financial results declared by the company on Monday (Photo source: Company website)</p></div>
ABB India Ltd.'s net profit rose 56% in the quarter ended December, according to the financial results declared by the company on Monday (Photo source: Company website)

ABB India Ltd.'s net profit rose 56% in the quarter ended December, according to the financial results declared by the company on Monday.

The net profit in the fourth quarter of the calendar year — the company follows the January-December fiscal cycle — came in at Rs 528.4 crore, as against Rs 338.7 crore in the year-ago period.

ABB India Q4 CY24 Highlights (YoY)

  • Revenue rose 22% to Rs 3,364.9 crore versus Rs 2,757.5 crore.

  • Ebitda rose 58% to Rs 657.3 crore versus Rs 417.2 crore.

  • Ebitda margin expanded to 19.5% versus 15.1%.

  • Net profit up 56% at Rs 528.4 crore versus Rs 338.7 crore.

  • The board recommended a final dividend of Rs 33.50 per share

Opinion
RVNL Q3 Results: Profit Down 13%, Misses Estimates

Order Book

Total orders for the fourth quarter was at Rs 2,695 crore and for 2024 was Rs 13,079 crore. Base orders for the quarter grew 4%, while total orders were down 14% due to the impact of a large order in both the motion and process automation business areas in the same quarter of 2023.

Large orders were up 20% and total orders grew 5%, driven by growth in segments like data centres and railways. Order backlog as of December stood at Rs 9,380 crore, an increase of 12%.

Opinion
BSNL Q3 Results: First Quarterly Profit Since 2007

The board recommended a final dividend of Rs 33.50 per share. This is in addition to the interim dividend of Rs 10.66 per share declared in the second quarter. The total dividend increased by 51% as compared to 2023.

Shares of ABB India closed 0.34% lower at Rs 5,241.20 apiece on the BSE before the results were announced, compared to a 0.08% rise in the benchmark Sensex.

Opinion
Glenmark Pharma Q3 Results: Company Reports Profit, Revenue Rises 35%
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit